Goldman Sachs Group Inc Petmed Express Inc Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Petmed Express Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 28,722 shares of PETS stock, worth $57,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,722

Previous 21,566 33.18%

Holding current value

$57,444

Previous $71,000 1.41%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$2.51 - $3.98 $17,961 - $28,480	7,156 Added 33.18%	28,722 $72,000
Q2 2025 Aug 14, 2025	SELL	$3.01 - $4.19 $35,045 - $48,784	-11,643 Reduced 35.06%	21,566 $71,000
Q1 2025 May 09, 2025	BUY	$3.95 - $5.51 $48,822 - $68,103	12,360 Added 59.28%	33,209 $139,000
Q4 2024 Feb 11, 2025	SELL	$3.7 - $6.6 $67,391 - $120,212	-18,214 Reduced 46.63%	20,849 $100,000
Q3 2024 Nov 14, 2024	SELL	$2.94 - $4.04 $884,684 - $1.22 Million	-300,913 Reduced 88.51%	39,063 $143,000

Q2 2024 Aug 13, 2024	BUY	$3.95 - $4.84 $1.04 Million - $1.27 Million	263,037 Added 341.88%	339,976 $1.38 Million
Q1 2024 May 15, 2024	BUY	$4.7 - $7.58 $144,553 - $233,130	30,756 Added 66.6%	76,939 $368,000
Q4 2023 Feb 13, 2024	SELL	$6.89 - $11.04 $317,787 - $509,197	-46,123 Reduced 49.97%	46,183 $349,000
Q3 2023 May 14, 2024	BUY	$10.21 - $14.65 $470,915 - $675,701	46,123 Added 99.87%	92,306 $946,000
Q3 2023 Nov 14, 2023	SELL	$10.21 - $14.65 $1.57 Million - $2.25 Million	-153,885 Reduced 62.51%	92,306 $946,000
Q2 2023 May 14, 2024	BUY	$13.68 - $16.56 $836,190 - $1.01 Million	61,125 Added 33.03%	246,191 $3.39 Million
Q2 2023 Aug 14, 2023	BUY	$13.68 - $16.56 $836,190 - $1.01 Million	61,125 Added 33.03%	246,191 $3.39 Million
Q1 2023 May 14, 2024	SELL	$15.9 - $22.22 $139,061 - $194,336	-8,746 Reduced 4.51%	185,066 $3.01 Million
Q1 2023 May 11, 2023	SELL	$15.9 - $22.22 $139,061 - $194,336	-8,746 Reduced 4.51%	185,066 $3.01 Million
Q4 2022 May 14, 2024	SELL	$17.16 - $22.14 $468,639 - $604,643	-27,310 Reduced 12.35%	193,812 $3.43 Million
Q4 2022 Feb 13, 2023	SELL	$17.16 - $22.14 $468,639 - $604,643	-27,310 Reduced 12.35%	193,812 $3.43 Million
Q3 2022 May 14, 2024	BUY	$19.35 - $23.52 $583,983 - $709,833	30,180 Added 15.81%	221,122 $4.32 Million
Q3 2022 Nov 10, 2022	BUY	$19.35 - $23.52 $583,983 - $709,833	30,180 Added 15.81%	221,122 $4.32 Million
Q2 2022 May 14, 2024	BUY	$19.9 - $26.13 $2.88 Million - $3.78 Million	144,759 Added 313.45%	190,942 $3.8 Million
Q2 2022 Aug 15, 2022	BUY	$19.9 - $26.13 $209,944 - $275,671	10,550 Added 5.85%	190,942 $3.8 Million
Q1 2022 May 16, 2022	BUY	$23.62 - $29.18 $2.19 Million - $2.71 Million	92,767 Added 105.87%	180,392 $4.65 Million
Q4 2021 Feb 14, 2022	SELL	$25.26 - $32.0 $49,888 - $63,200	-1,975 Reduced 2.2%	87,625 $2.21 Million
Q3 2021 Nov 10, 2021	BUY	$26.5 - $34.0 $2.37 Million - $3.05 Million	89,600 New	89,600 $2.41 Million

Others Institutions Holding PETS

# of Institutions

Shares Held

7.25M

Call Options Held

28.1K

Put Options Held

68.7K

View Full List

About PETMED EXPRESS INC

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $42M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

More about PETS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Petmed Express Inc Transaction History